Getting Bang for Your Buck: Spend Your 2025 Privacy Budget Wisely
No Password Required: Director and Cybersecurity Adviser at KPMG and Rain Culture Authority
Navigating the Regulation Jungle: How to Be Compliant, Work Efficiently, and Stay Sane
The ‘Long Arm’ of CIPA and Its Newfound Pen-Trap Claims
Privacy Litigation Trends: Meta Pixels, Cookie Opt-Out, and Sale of Data
Fashion Counsel: Privacy in the Retail Fashion Industry
Healthcare Privacy Walkthroughs
CF on Cyber: An Update on the Florida Security of Communications Act (FSCA)
NGE On Demand: Privacy Considerations for Remote Work Productivity Monitoring with David Wheeler
I Wish I Knew What I Know Now: Conversations with AGG on FDA Issues - Data Privacy Issues Life Sciences Companies May Encounter
Education Data Privacy and Security Laws: Best Practices for School Districts
Compliance Perspectives: Permissible Disclosures under HIPAA, Especially in the Time of COVID-19
E14: The Three Pillars of GDPR
E13: GDPR Wedding Day & Beyond
BakerHostetler Partner Alan Friel Talks Big Data and Data Collection
IP|Trend: It’s Time to Get to Know the Federal Trade Commission
IP|Trend: Keeping Your Start-Up Compliant
Yul Kwon, Head of @Facebook's Privacy Program & CBS 'Survivor' Winner, Opens Up On @HsuUntied
An Overview of the 2014 Class Action Survey
Can a website copy terms of use or a privacy policy from a similar website?
On March 23, 2025, 23andMe, along with its affiliates, filed for voluntary Chapter 11 bankruptcy. The company’s decision to file for bankruptcy follows in the wake of a 2023 data breach affecting close to 7 million customer...more
In a March 31, 2025 letter, the Chair of the FTC, Andrew Ferguson, wrote to the Acting U.S. Bankruptcy Trustee and set out the FTC’s expectations for the protection of consumer information held by 23andMe. As we noted...more
The chapter 11 bankruptcy cases of 23andMe Holding Co. and its affiliated debtors (collectively, “23andMe”), the company that provides direct-to-consumer genetic testing and ancestry services, has prompted a wave of panicked...more
On January 12, 23andMe announced an agreement with Pfizer to provide the drug company with access to anonymous, aggregated information from consumers who bought 23andMe’s test over the past seven years to learn about their...more